Bond.az White LogoBond.az Black Logo

TD Cowen Reiterates Hold on Infosys, $13 Target

TD Cowen analyst reiterates Hold rating on Infosys with $13 target. AI impacts and market dynamics in focus.

Isabella Martinez
ByIsabella Martinez- Senior Editor
|
0

TD Cowen analyst Bryan Bergin reiterated a Hold rating and $13.00 price target on Infosys Technologies (NYSE:INFY). The stock currently trades at $11.66, near its 52-week low of $11.55, reflecting a challenging year with shares down 36%.

The firm hosted Sandeep Mahindroo, Controller & Head of IR, for investor meetings. Key topics included enterprise demand, competitive intensity, AI impacts and opportunities, organic investments, and capital allocation.

Infosys remains guarded on the near-term outlook as discretionary spending stays muted and decision cycles slowed in late March and April due to Iran uncertainty. AI-driven deflation is becoming more visible.

The company's positive medium-term view is unchanged, based on six key AI value pools: data, modernization, process/agentification, and governance. It believes these will outstrip AI deflation over the medium to long term. However, a timing gap exists as FY27 growth remains muted.

TD Cowen expects continued scrutiny on volume/revenue conversion, discretionary softness, and AI-driven commercial pressure in the near term.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
841

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
TD Cowen Reiterates Hold on Infosys, $13 Target | Bond.az